Loading company…
NovaDigm Therapeutics develops vaccines and therapies for infectious diseases.
Founded in 2005 and based in Brookline, NovaDigm Therapeutics develops vaccines and therapies, including products intended to address fungal infections. The company raised USD 7.01 mn in a Series B round in October 2013, with RMI Partners as lead investor and Domain Associates as a returning investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in